Tag: Neurolief
Interim analysis of MOOD trial produces positive neuromodulation data in depression...
Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel...
The first non-invasive, adaptive neuromodulation digital treatment for migraine receives CE...
Neurolief, a developer of digital therapeutics brain neuromodulation technology, has announced that it has received the CE mark for its Relivion non-invasive, adaptive digital treatment...
